Dr Yadav received her MD degree from All India Institute of Medical Sciences, New Delhi. She most recently completed a Nuclear Medicine Residency at New York Presbyterian Hospital/Weill Cornell Medicine, where she also served as Chief Resident. Dr Yadav's clinical focus is on therapeutics using targeted radionuclide therapies for prostate, neuroendocrine, and thyroid cancers. Her research interests are utilizing newer radiotracers, including fibroblast activation protein inhibitor (FAPI) and hypoxia imaging, for imaging and treating various oncologic conditions. Her research focus on investigating the clinical use of dosimetry in personalized radionuclide treatment in prostate cancer patients.